Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMU2F6Q)

• Drug Name: ZD-6003 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Terminated	[1]

• Cross-matching ID: TTD Drug ID: DMU2F6Q

Molecule-Related Drug Atlas

Drug(s) Targeting Granulocyte colony-stimulating factor receptor (G-CSF-R)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tbo-Filgrastim	DML6OE7	Neutropenia	4B00.0	Approved	[3]
Pegfilgrastim	DM7UP8X	Central nervous system neoplasm		Approved	[4]
Peg-G-CSF	DMBKWAF	Solid tumour/cancer	2A00-2F9Z	Phase 3	[2]
BLZ-945	DMG1LVA	Amyotrophic lateral sclerosis	8B60.0	Phase 2	[2]
SBC-014	DMG1VXR	Neutropenia	4B00.0	Phase 2	[5]
AX-200	DMTAEMB	Cardiovascular disease	BA00-BE2Z	Phase 2	[6]
MAXY-G34	DMWLIPJ	Neutropenia	4B00.0	Phase 2	[7]
PLX7486	DM0IVGU	Pancreatic cancer	2C10	Phase 1	[8]
AMG 820	DMB6Q19	Solid tumour/cancer	2A00-2F9Z	Phase 1	[9]
MK-6302	DMZUA5C	Neutropenia	4B00.0	Phase 1	[10]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Granulocyte colony-stimulating factor receptor (G-CSF-R)	TTC70AJ	CSF3R_HUMAN	Modulator	[2]

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003738)
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1719).
• [3] Nat Rev Drug Discov. 2013 Feb;12(2):87-90.
• [4] Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model. Pharmacol Res. 2004 Jul;50(1):55-8.
• [5] A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study. BMC Clin Pharmacol. 2009; 9: 2.
• [6] Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke. 2013 Oct;44(10):2681-7.
• [7] Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors. Health Phys. 2014 Jan;106(1):21-38.
• [8] National Cancer Institute Drug Dictionary (drug id 747694).
• [9] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [10] Merck ditches biogeneric. Nat Biotechnol. 2010 Jul;28(7):636.